Hopfner Robert Lorne

Transactions récentes

…

InsiderLens

USPersonne physique

Hopfner Robert Lorne

Transactions totales: 92
Entreprises: 4
Achats / Ventes: 12 / 40
Dernière transaction: 19 déc. 2025

Transactions récentes

19 déc. 2025PURCHASEEvommune, Inc.1 00017.35 USD
indirect· By Trust
07 nov. 2025CONVERSIONEvommune, Inc.3 026—
indirect· By Trust
07 nov. 2025CONVERSIONEvommune, Inc.1 441 032—
indirect· By NFLS Delta III Limited
07 nov. 2025CONVERSIONEvommune, Inc.294 502—
indirect· By Pivotal bioVenture Partners Fund II, L.P.
07 nov. 2025CONVERSIONEvommune, Inc.1 632 441—
indirect· By Pivotal bioVenture Partners Fund I, L.P.
07 nov. 2025CONVERSIONEvommune, Inc.7 230 283—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.25 790—
indirect· By Trustderiv
07 nov. 2025CONVERSIONEvommune, Inc.7 145 647—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.3 572 816—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.2 582 243—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.2 508 575—
indirect· By Pivotal bioVenture Partners Fund II, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.1 895 260—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.2 104 740—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.313 571—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.313 571—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
01 juil. 2025TENDERInozyme Pharma, Inc.2 923 1104.00 USD
indirect· By Pivotal
01 juil. 2025TENDERInozyme Pharma, Inc.1 571 7414.00 USD
indirect· By Pivotal
13 mai 2025GRANT_AWARDRallybio Corp28 5000.00 USD
détention directederiv
02 janv. 2025GRANT_AWARDRallybio Corp73 5710.70 USD
détention directederiv
18 juin 2024GRANT_AWARDInozyme Pharma, Inc.28 0000.00 USD
détention directederiv
15 mai 2024GRANT_AWARDRallybio Corp16 5000.00 USD
détention directederiv
01 août 2023PURCHASEInozyme Pharma, Inc.119 0484.80 USD
indirect· By Pivotal
01 août 2023PURCHASEInozyme Pharma, Inc.714 2854.80 USD
indirect· By Pivotal
13 juin 2023GRANT_AWARDInozyme Pharma, Inc.16 0000.00 USD
détention directederiv
17 mai 2023GRANT_AWARDRallybio Corp15 4900.00 USD
détention directederiv

…

19 déc. 2025PURCHASEEvommune, Inc.1 00017.35 USD
indirect· By Trust
07 nov. 2025CONVERSIONEvommune, Inc.3 026—
indirect· By Trust
07 nov. 2025CONVERSIONEvommune, Inc.1 441 032—
indirect· By NFLS Delta III Limited
07 nov. 2025CONVERSIONEvommune, Inc.294 502—
indirect· By Pivotal bioVenture Partners Fund II, L.P.
07 nov. 2025CONVERSIONEvommune, Inc.1 632 441—
indirect· By Pivotal bioVenture Partners Fund I, L.P.
07 nov. 2025CONVERSIONEvommune, Inc.7 230 283—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.25 790—
indirect· By Trustderiv
07 nov. 2025CONVERSIONEvommune, Inc.7 145 647—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.3 572 816—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.2 582 243—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.2 508 575—
indirect· By Pivotal bioVenture Partners Fund II, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.1 895 260—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.2 104 740—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
07 nov. 2025CONVERSIONEvommune, Inc.313 571—
indirect· By NFLS Delta III Limitedderiv
07 nov. 2025CONVERSIONEvommune, Inc.313 571—
indirect· By Pivotal bioVenture Partners Fund I, L.P.deriv
01 juil. 2025TENDERInozyme Pharma, Inc.2 923 1104.00 USD
indirect· By Pivotal
01 juil. 2025TENDERInozyme Pharma, Inc.1 571 7414.00 USD
indirect· By Pivotal
13 mai 2025GRANT_AWARDRallybio Corp28 5000.00 USD
détention directederiv
02 janv. 2025GRANT_AWARDRallybio Corp73 5710.70 USD
détention directederiv
18 juin 2024GRANT_AWARDInozyme Pharma, Inc.28 0000.00 USD
détention directederiv
15 mai 2024GRANT_AWARDRallybio Corp16 5000.00 USD
détention directederiv
01 août 2023PURCHASEInozyme Pharma, Inc.119 0484.80 USD
indirect· By Pivotal
01 août 2023PURCHASEInozyme Pharma, Inc.714 2854.80 USD
indirect· By Pivotal
13 juin 2023GRANT_AWARDInozyme Pharma, Inc.16 0000.00 USD
détention directederiv
17 mai 2023GRANT_AWARDRallybio Corp15 4900.00 USD
détention directederiv